| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| Z0024 | TCI | Zolmitriptan | >98.0%(T)(HPLC) | 275元/200MG; 885元/1G; | 咨询 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C16H21N3O2 = 287.36 | | 外观与形状(20℃) | 固体 | | 储存温度 | 0-10℃ | | 应避免的情况 | 加热 | | 包装和容器 | 200MG-带有塑料内管的玻璃瓶 (查看图片) | | Reaxys-RN | 7415010 | | PubChem物质ID | 253659590 | | Merck Index (14) | 10189 | | MDL编号 | MFCD00871503 |
技术规格 | Appearance | White to Orange to Green powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Melting point | 136.0 to 140.0 ℃ | | Specific rotation [a]20/D | -3.0 to -5.0 deg(C=1、MeOH) |
物性(参考值) | 熔点 | 138 ℃ | | 比旋光度 [α]D | -4° (C=1,MeOH) | | 最大吸收波长 | 225 nm |
安全信息 | 图形或危害标志 |  | | 信号词 | 警告 | | 危险性说明 | H302 : 吞咽有害。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P301 + P312 + P330 : 如误吞咽:如感觉不适,呼叫急救中心/医生。漱口。
|
相关法规 |
| 377186 | J&K | Zolmitriptan | 98%, 一种选择性5-HT1B/1D/1F受体激动剂 | 261元/200MG; 841元/1G; | 咨询 |
基本信息 | 分子式 | C16H21N3O2 | | 分子量 | 287.36 | | 熔点 | 138 | | 比旋光度([α]20D) | -8 to -3 (C=1, MeOH) | | MDL编码 | MFCD00871503 | | Beilstein | 7415010 | | Merck | 14,10189 | | 存储条件 | Freezer -20℃ | 产品描述 Zolmitriptan 是一种选择性5-羟色胺受体激动剂。 靶点(IC50 & Targe) 5-HT 体外研究 在灵长类动物基底动脉和人的心外膜冠状动脉环中,Zolmitriptan产生浓度依赖性收缩。在转染的CHO-K1细胞膜中,Zolmitriptan显示人类重组5-HT1D(前5-HT1D alpha)和5-HT1B(前5-HT1D beta)受体的高亲和力。[1] 在表达重组人5-HT(1B)受体的C6胶质瘤细胞中,Zolmitriptan以浓度依赖的方式增加I(K)(最大增加16.3%),pD(2) 值为7.03。在表达克隆的人5-HT(1B)受体的C6细胞中,Zolmitriptan诱导的I(K)为钙离子螯合剂EGTA(5 mM)所抑制。[2] 体内研究 在麻醉豚鼠同侧硬脑膜中,Zolmitriptan(3-30 毫克/千克,静脉注射)在三叉神经节的单方面电刺激前十分钟给药剂量依赖性抑制[125I]血浆蛋白外渗。[1] Zolmitriptan(10-1000 毫克/千克,静脉注射)选择性降低动静脉-吻合(AVA)电导产生最大降低达到92.5%。Zolmitriptan也产生脑外电导的适度减少(最大减少23.9%,30 毫克/公斤,静脉注射),但不影响大脑电导的影响。在麻醉猫中,Zolmitriptan(1-30 毫克/千克,静脉注射)在耳微血管电导中产生剂量依赖性降低,它降低颈动脉微血管电导。[3] 在小鼠中,Zolmitriptan发挥行为上特异性抗攻击性的影响。在小鼠中,Zolmitriptan也降低酒精加强攻击性。[4] 参考文献 [1] Martin GR, et al. Br J Pharmacol,?997, 121(2), 157-164. [2] Le Grand B, et al. Eur J Pharmacol,?000, 397(2-3), 297-302. [3] MacLennan SJ, et al. Eur J Pharmacol,?998, 361(2-3), 191-197. [4] de Almeida RM, et al. Psychopharmacology (Berl),?001, 157(2 安全信息 | 图形或危害标志 |  | | 提示语 | Warning | | 危险说明 | H302 | | 防范说明 | P264 P270 P301+P312+P330 P501 | | WGK | 3 | | RTECS | RQ2707000 |
|
| Y0001975 | | Zolmitriptan | European Pharmacopoeia (EP) Reference Standard | 1259.15元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Zolmitriptan is a selective serotonin receptor agonist of the 5HT1B and 5HT1D subtypes, both centrally and peripherally. It has been used clinically for the acute treatment of migraine attacks with or without aura and cluster headaches. 包装 Unit quantity: 30 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C16H21N3O2 | | 分子量 | 287.36 | | MDL编号 | MFCD00871503 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | | InChI | 1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1 | | InChI key | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | | Gene Information | human ... HTR1B(3351), HTR1D(3352) |
安全信息 | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1727009 | USP | Zolmitriptan | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Zolmitriptan is a selective serotonin receptor agonist of the 5HT1B and 5HT1D subtypes, both centrally and peripherally. It has been used clinically for the acute treatment of migraine attacks with or without aura and cluster headaches. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C16H21N3O2 | | 分子量 | 287.36 | | MDL编号 | MFCD00871503 | | PubChem化学物质编号 | 329751294 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 15-25℃ | | SMILES string | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | | InChI | 1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1 | | InChI key | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | | Gene Information | human ... HTR1B(3351), HTR1D(3352) |
安全信息 | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0001991 | | Zolmitriptan for system suitability | European Pharmacopoeia (EP) Reference Standard | 1414.22元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Zolmitriptan is a selective serotonin receptor agonist of the 5HT1B and 5HT1D subtypes, both centrally and peripherally. It has been used clinically for the acute treatment of migraine attacks with or without aura and cluster headaches. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C16H21N3O2 | | 分子量 | 287.36 | | MDL编号 | MFCD00871503 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 | | InChI | 1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1 | | InChI key | ULSDMUVEXKOYBU-ZDUSSCGKSA-N | | Gene Information | human ... HTR1B(3351), HTR1D(3352) |
安全信息 | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 036593 | Fluorochem | (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one | 97% | 1408元/1g; 32714元/25g; | 咨询 |
基本信息 | CAS Number | 139264-17-8 | | MDL Number | MFCD00871503 | | Melting Point | 138℃ |
安全信息 | 图形或危害标志 |   | | 危险性说明 | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. H371: May cause damage to organs (eyes).
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P301 + P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: . P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P309: IF exposed or if you feel unwell: . P309 + P311: IF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician. P311: Call a POISON CENTER or doctor/physician. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see . on this label). P330: Rinse mouth. P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to local regulations.
|
|